Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × High Grade Serous Carcinoma × ceralasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Neoplasms 6 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinosarcoma 2 Bile Duct Neoplasms 2 Advanced Solid Tumours 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumour Refractory to Conventional Treatment 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 SCLC 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Osteosarcoma 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms by Site 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

olaparib 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03462342 2026-03-17

CAPRI

University of Pennsylvania

Phase 2 Completed

High Grade Serous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡